Date of first participant enrolmentAnticipated15/01/2024
https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=385922&isReview=true&fbclid=IwAR1xc4Fq-4GGYxRgQ-pAiQbmlFFGsPmlHhbopn6N4XB61f4S18WNe8swv1kWelcome back to 2024!This year is gearing up to be even bigger than 2023 for Argenica Therapeutics, with Phase 2 clinical trial in acute ischaemic stroke (AIS) patients right around the corner.If you missed it, last month we provided a company update that addressed the current status of the clinical trial.⬇ You can find the announcement here ⬇ AGN investor announcement: https://bit.ly/3NVPdWu#ASX#AGN#investor#clinicaltrial#clinicaltrialupdate#stroke#strokeawareness
https://www.linkedin.com/posts/argenica-therapeutics_asx-agn-investor-activity-7149920317258293248-jYR_
Add to My Watchlist
What is My Watchlist?